These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18078390)

  • 21. Novel approaches to the pharmacotherapy of pulmonary arterial hypertension.
    Olsson KM; Hoeper MM
    Drug Discov Today; 2009 Mar; 14(5-6):284-90. PubMed ID: 19121410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary hypertension and the serotonin hypothesis: where are we now?
    MacLean MR
    Int J Clin Pract Suppl; 2007 Sep; (156):27-31. PubMed ID: 17663674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin and pulmonary hypertension--from bench to bedside?
    MacLean MR; Dempsie Y
    Curr Opin Pharmacol; 2009 Jun; 9(3):281-6. PubMed ID: 19286424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Novel concepts in the pathobiology of pulmonary arterial hypertension].
    Rosenkranz S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S167-9. PubMed ID: 18814087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Calcium and stored-operated Ca2+ channels in pulmonary vascular remodeling].
    Wang J; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):784-6. PubMed ID: 18218215
    [No Abstract]   [Full Text] [Related]  

  • 26. The vasoactive intestinal peptide gene is a key modulator of pulmonary vascular remodeling and inflammation.
    Said SI
    Ann N Y Acad Sci; 2008 Nov; 1144():148-53. PubMed ID: 19076374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension.
    Peled N; Shitrit D; Fox BD; Shlomi D; Amital A; Bendayan D; Kramer MR
    J Rheumatol; 2009 May; 36(5):970-5. PubMed ID: 19369472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy.
    Dimopoulos K; Peset A; Gatzoulis MA
    Int J Cardiol; 2008 Sep; 129(2):163-71. PubMed ID: 18367267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis.
    Kowal-Bielecka O; Delcroix M; Vonk-Noordegraaf A; Hoeper MM; Naeije R
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v39-41. PubMed ID: 18784140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Update: Current clinical developments in pulmonary hypertension].
    Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DHEA treatment of pulmonary hypertension: new insights into a complex mechanism.
    Dubuis E
    Cardiovasc Res; 2007 Jun; 74(3):337-8. PubMed ID: 17466961
    [No Abstract]   [Full Text] [Related]  

  • 32. Tormentic acid reduces vascular smooth muscle cell proliferation and survival.
    Fogo AS; Antonioli E; Calixto JB; Campos AH
    Eur J Pharmacol; 2009 Aug; 615(1-3):50-4. PubMed ID: 19464287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Update in basic research in the therapy of pulmonary arterial hypertension].
    Schermuly R; Grimminger F
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S170-2. PubMed ID: 18814088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferation and apoptosis of vascular smooth muscle in hypertension.
    Hamet P
    Curr Opin Nephrol Hypertens; 1995 Jan; 4(1):1-7. PubMed ID: 7743153
    [No Abstract]   [Full Text] [Related]  

  • 35. Endothelial-to-Mesenchymal Transition: An Evolving Paradigm and a Promising Therapeutic Target in PAH.
    Stenmark KR; Frid M; Perros F
    Circulation; 2016 May; 133(18):1734-7. PubMed ID: 27045137
    [No Abstract]   [Full Text] [Related]  

  • 36. Growth factors: regulation of normal and neoplastic growth.
    Pusztai L; Lewis CE; Lorenzen J; McGee JO
    J Pathol; 1993 Feb; 169(2):191-201. PubMed ID: 8445485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell growth control takes balance.
    Marx JL
    Science; 1988 Feb; 239(4843):975-6. PubMed ID: 3422766
    [No Abstract]   [Full Text] [Related]  

  • 38. Disregulation process of cancer cell proliferation.
    Kresno SB; Gondhowiardjo S
    Acta Med Indones; 2004; 36(3):169-76. PubMed ID: 15557688
    [No Abstract]   [Full Text] [Related]  

  • 39. Sharp strategy needed with new treatment options for PAH.
    Morrow T
    Manag Care; 2006 Mar; 15(3):66-7. PubMed ID: 16604932
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferons and cell growth regulation.
    Quesada JR; Gutterman JU
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1213-5. PubMed ID: 6208033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.